ER-100

N/A

Report date: 2026/03/10 20:00:16

Base Information

Drug NameER-100
Drug Alias NameER 100ER100
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsGlaucoma, Open-AngleOptic Neuropathy, Ischemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHarvard University
China Registration ClassN/A

Develop Information

Active CompaniesLife Biosciences Inc
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-AngleOptic Neuropathy, Ischemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A